Stockscreener 앱 받기
219.16
0.05%
0.12
전일 마감가:
$219.04
열려 있는:
$219.31
하루 거래량:
4.60M
Relative Volume:
0.85
시가총액:
$387.16B
수익:
$59.64B
순이익/손실:
$2.36B
주가수익비율:
165.37
EPS:
1.3253
순현금흐름:
$19.68B
1주 성능:
+0.51%
1개월 성능:
-5.87%
6개월 성능:
+16.52%
1년 성능:
+9.30%
1일 변동 폭
$217.09
$220.99
1주일 범위
$211.69
$220.99
52주 변동 폭
$163.81
$244.81
애브비 Stock (ABBV) Company Profile
명칭
Abbvie Inc
전화
(847) 932-7900
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
ABBV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
219.16 | 387.13B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
LLY
Lilly Eli Co
|
924.37 | 839.03B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.57 | 450.47B | 92.15B | 25.12B | 20.46B | 10.36 |
|
NVS
Novartis Ag Adr
|
126.35 | 242.86B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
86.28 | 212.91B | 63.90B | 19.05B | 14.72B | 7.5596 |
애브비 Stock (ABBV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2025-10-14 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-01 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-09-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2025-08-12 | 재개 | Piper Sandler | Overweight |
| 2025-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-05 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-04 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-01-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-12-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-10-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-09-29 | 개시 | Raymond James | Outperform |
| 2023-07-25 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-05 | 다운그레이드 | Argus | Buy → Hold |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-11-08 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Underperform |
| 2022-05-06 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2022-02-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-03 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재확인 | Barclays | Equal Weight |
| 2022-02-03 | 재확인 | BofA Securities | Neutral |
| 2022-02-03 | 재확인 | Goldman | Neutral |
| 2022-01-13 | 개시 | Redburn | Buy |
| 2022-01-12 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-11-23 | 업그레이드 | Societe Generale | Hold → Buy |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-23 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 업그레이드 | Argus | Hold → Buy |
| 2020-05-18 | 재개 | BofA/Merrill | Neutral |
| 2020-05-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 재개 | Morgan Stanley | Overweight |
| 2020-04-20 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 재확인 | Cowen | Outperform |
| 2019-09-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-20 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-04-29 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
모두보기
애브비 주식(ABBV)의 최신 뉴스
Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating - Insider Monkey
Should AbbVie's (ABBV) Dividend Hike and Lower Guidance Prompt a Closer Look at Earnings Stability? - simplywall.st
UBS Adjusts Price Target on AbbVie to $220 From $195, Maintains Neutral Rating - MarketScreener
ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB) - GlobeNewswire Inc.
Harvest Portfolios Group Inc. Has $55.10 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Shaping the future of science, together - AbbVie
The Top 5 Analyst Questions From AbbVie’s Q3 Earnings Call - The Globe and Mail
How AbbVie Inc. (4AB) stock benefits from digital adoptionJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Why AbbVie Inc. stock is trending among retail traders2025 Support & Resistance & Long Hold Capital Preservation Tips - fcp.pa.gov.br
How AbbVie Inc. (4AB) stock performs in volatility spikes2025 Big Picture & Short-Term High Return Strategies - newser.com
Is AbbVie Inc. stock resilient to inflationJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com
Will AbbVie Inc. stock attract more institutional investors2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Is AbbVie Inc. (4AB) stock undervalued after correctionExit Point & Momentum Based Trading Ideas - newser.com
Market Rankings: Can AbbVie Inc. stock retain market dominanceGold Moves & Fast Moving Trade Plans - fcp.pa.gov.br
Is AbbVie Inc. stock undervalued vs historical averagesWeekly Trend Report & Growth Focused Investment Plans - fcp.pa.gov.br
Analyzing AbbVie Inc. with risk reward ratio chartsMarket Movement Recap & Risk Controlled Swing Trade Alerts - newser.com
Jim Cramer Says “I Found the AbbVie Call Particularly Jarring” - MSN
Will AbbVie Inc. stock reach all time highs in 2025July 2025 Chart Watch & High Conviction Buy Zone Picks - fcp.pa.gov.br
AbbVie Just Raised Its Dividend by 5.5%. Should You Buy ABBV Stock Here? - Barchart.com
Ironwood wins new FDA nod for AbbVie-partnered bowel drug - Seeking Alpha
ABBV Receives New Price Target and Overweight Rating from Piper Sandler | ABBV Stock News - GuruFocus
AbbVie's (ABBV) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - Yahoo Finance
FY2025 EPS Estimates for AbbVie Reduced by Cantor Fitzgerald - MarketBeat
First Horizon Advisors Inc. Boosts Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Genus Capital Management Inc. - MarketBeat
Can AbbVie Inc. stock retain market dominanceJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
AbbVie Inc. $ABBV Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
AbbVie Inc. $ABBV is Commonwealth Retirement Investments LLC's 4th Largest Position - MarketBeat
Jacobson & Schmitt Advisors LLC Takes $377,000 Position in AbbVie Inc. $ABBV - MarketBeat
Claro Advisors LLC Lowers Holdings in AbbVie Inc. $ABBV - MarketBeat
Corps Capital Advisors LLC Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Why AbbVie Inc. (4AB) stock stays on top picksMarket Trend Review & Growth Focused Stock Reports - newser.com
Using R and stats models for AbbVie Inc. forecastingBond Market & AI Powered Market Trend Analysis - newser.com
How to recover losses in AbbVie Inc. stockMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is AbbVie Inc. stock a buy on dipsOil Prices & Risk Managed Investment Signals - newser.com
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight - GuruFocus
AbbVie (NYSE:ABBV) Shares Up 1.9% After Analyst Upgrade - MarketBeat
AbbVie Inc. SEC 10-Q Report - TradingView
AbbVie (ABBV) Receives a Buy from BMO Capital - The Globe and Mail
Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain ShiftsGlobal Forecast to 2034 - Yahoo Finance
Bernstein raises AbbVie stock price target to $225 on long-term growth - Investing.com Nigeria
Bernstein Adjusts Price Target on AbbVie to $225 From $203, Maintains Market Perform Rating - MarketScreener
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More - Yahoo Finance
AbbVie (NYSE:ABBV) Downgraded to "Hold" Rating by DZ Bank - MarketBeat
AbbVie Inc. (NYSE:ABBV) Q3 2025 Earnings Call Transcript - Insider Monkey
Here Are Tuesday's Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More - 24/7 Wall St.
Tufton Capital Management Has $10.25 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Magnolia Capital Advisors LLC Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Code Waechter LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
EPG Wealth Management LLC Sells 2,439 Shares of AbbVie Inc. $ABBV - MarketBeat
애브비 (ABBV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.58%
자본화:
|
볼륨(24시간):